The treatment of spasticity with Δ9-tetrahydrocannabinol in persons with spinal cord injury

被引:0
|
作者
U Hagenbach
S Luz
N Ghafoor
J M Berger
F Grotenhermen
R Brenneisen
M Mäder
机构
[1] REHAB Basel,
[2] Centre for Spinal Cord Injury (SCI) and Severe Head Injury (SHI),undefined
[3] Nova-Institut,undefined
[4] Goldenbergstrasse 2,undefined
[5] Departement of Clinical Research,undefined
[6] University of Bern,undefined
来源
Spinal Cord | 2007年 / 45卷
关键词
spinal cord injury; spasticity; pain; THC; cannabinoid; cannabis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:551 / 562
页数:11
相关论文
共 50 条
  • [41] Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol
    Lile, Joshua A.
    Kelly, Thomas H.
    Pinsky, David J.
    Hays, Lon R.
    PSYCHOPHARMACOLOGY, 2009, 203 (02) : 241 - 250
  • [42] TREATMENT OF HUMAN SPASTICITY WITH DELTA-9-TETRAHYDROCANNABINOL
    PETRO, DJ
    ELLENBERGER, C
    JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9): : S413 - S416
  • [43] Muscle spasticity associated with reduced whole-leg perfusion in persons with spinal cord injury
    Dhindsa, Mandeep S.
    Merring, Curtis A.
    Brandt, Lauren E.
    Tanaka, Hirofumi
    Griffin, Lisa
    JOURNAL OF SPINAL CORD MEDICINE, 2011, 34 (06): : 594 - 599
  • [44] Determination of Δ9-tetrahydrocannabinol in food
    Georgi, K
    Mavric, E
    Speer, K
    DEUTSCHE LEBENSMITTEL-RUNDSCHAU, 2002, 98 (10) : 363 - 366
  • [45] Restorative treatment of persons with spinal cord injury: Current trends
    Ragnarsson, KT
    JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 1998, 35 (04): : XI - XIV
  • [46] Excretion of Δ9-tetrahydrocannabinol in sweat
    Huestis, Marilyn A.
    Scheidweiler, Karl B.
    Saito, Takeshi
    Fortner, Neil
    Abraham, Tsadik
    Gustafson, Richard A.
    Smith, Michael L.
    FORENSIC SCIENCE INTERNATIONAL, 2008, 174 (2-3) : 173 - 177
  • [47] Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol
    Chan, GCK
    Hinds, TR
    Impey, S
    Storm, DR
    JOURNAL OF NEUROSCIENCE, 1998, 18 (14): : 5322 - 5332
  • [48] The Pharmacokinetics of Δ9-Tetrahydrocannabinol in Sheep
    Stevens, Sarah A.
    Edwards, Scott H.
    Noble, Glenys K.
    Scrivener, Colin J.
    Krebs, Gaye L.
    Petzel, Christopher E.
    May, Christopher D.
    Tai, Zi Xuan
    Blake, Bronwyn L.
    Dods, Kenneth C.
    Warne, Leon N.
    ANIMALS, 2024, 14 (22):
  • [49] Δ9-Tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids
    Goodivin, Robert S.
    Gustafson, Richard A.
    Barnes, Allan
    Nebro, Wesenyalsh
    Moolchan, Eric T.
    Huestis, Marilyn A.
    THERAPEUTIC DRUG MONITORING, 2006, 28 (04) : 545 - 551
  • [50] Chemodenervation for treatment of limb spasticity following spinal cord injury: a systematic review
    J Lui
    M Sarai
    P B Mills
    Spinal Cord, 2015, 53 : 252 - 264